000			01907 a2200505 4500
005			20250517055513.0
264		0	_c20160429
008			201604s 0 0 eng d
022			_a1715-3360
024	7		_a10.1016/j.jcjo.2014.12.012 _2doi
040			_aNLM _beng _cNLM
100	1		_aMajor, James C
245	0	0	_aAflibercept for pigment epithelial detachment for previously treated neovascular age-related macular degeneration. _h[electronic resource]
260			_bCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _cOct 2015
300			_a373-7 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aBevacizumab _xtherapeutic use
650	0	4	_aDrug Substitution
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIntravitreal Injections
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aRanibizumab _xtherapeutic use
650	0	4	_aReceptors, Vascular Endothelial Growth Factor _xtherapeutic use
650	0	4	_aRecombinant Fusion Proteins _xtherapeutic use
650	0	4	_aRetinal Detachment _xdiagnosis
650	0	4	_aRetinal Pigment Epithelium _xdrug effects
650	0	4	_aRetrospective Studies
650	0	4	_aTomography, Optical Coherence
650	0	4	_aVascular Endothelial Growth Factor A _xantagonists & inhibitors
650	0	4	_aVisual Acuity _xdrug effects
650	0	4	_aWet Macular Degeneration _xdrug therapy
700	1		_aWykoff, Charles C
700	1		_aCroft, Daniel E
700	1		_aWang, Rui
700	1		_aMariani, Angeline F
700	1		_aLehmann, Anna E
700	1		_aBrown, David M
773	0		_tCanadian journal of ophthalmology. Journal canadien d'ophtalmologie _gvol. 50 _gno. 5 _gp. 373-7
856	4	0	_uhttps://doi.org/10.1016/j.jcjo.2014.12.012 _zAvailable from publisher's website
999			_c25343441 _d25343441